Oncology
Conference Coverage
Collagen ‘tile’ delivers postsurgical radiation in glioblastoma
If replicated in larger trials, GT therapy “could define a new standard of care, and there would really be no reason why patients shouldn’t get...
From the Journals
Bariatric surgery cuts risk of developing and dying from cancer
“The magnitude of the benefit was very large and dose-dependent.”
Conference Coverage
Mohs surgery in the elderly: The dilemma of when to treat
“The take-home point for me is to treat your whole patient, not just the tumor.”
From the Journals
Jury is in? Survival benefit with lap surgery for rectal cancer
The faster recovery from the minimally invasive procedure could allow patients to begin adjuvant therapy earlier.
From the Journals
Cancer patients unaware of their increased thrombosis risk
“These professionals are on the front line of the battle; they are among the first healthcare workers given the chance to suspect a clot and...
Conference Coverage
Bupivacaine following Mohs surgery reduces opioid use, study finds
Recent research has shown that Mohs micrographic surgeons have the highest rates of opioid prescribing of all dermatologists.
Latest News
Doctor accused of ‘fraudulent concealment’ can’t be held liable
The Iowa Supreme Court dismissed a knotty claim against a local doctor and hospital accused of concealing a woman’s renal cancer.
Feature
Q&A with Hubert (Hugh) Greenway, MD
“Every patient who comes to see me has a story, so I try to understand their story,” Dr. Hugh Greenway said.
Conference Coverage
Which solid organ transplant recipients face the highest risk of skin cancer?
Those at low risk for skin cancer include abdominal organ recipients, SOTR age of younger than 50 at time of transplant, and female gender.
From the Journals
Which breast cancer surgery leads to better quality of life?
Superior psychosocial and sexual well-being at 10 years after surgery was reported by women who underwent breast-conserving surgery and adjuvant...
From the Journals
Surgery shows no survival, morbidity benefit for mild hyperparathyroidism
A decade-long randomized trial shows nearly identical outcomes in most measures in patients with mild parathyroid tumors who did and did not...